Clinical trials have demonstrated that tirzepatide produces substantial weight loss, with patients without diabetes achieving approximately 15-20% body weight reduction at the highest doses in the SURMOUNT trialssignificantly greater than results observed with selective GLP-1 receptor agonists
MAHOLOPA LAVEIL and MICHAEL KABUNI investigate whether the funds really do help hold together governing coalitions and assist MPs in their quest for re-election
Melanocytes make the pigment known as melanin and disperse it to cells that need UV protection
Such trials could examine whether the drugs reduce overdose rates and drug-related deaths
In future, it is likely that the clinical indications for GLP- 1RAs will expand, with pharmaceutical companies running various drug trials to substantiate a wider array of use cases, such as the reduction of cardiovascular risk and the treatment of chronic kidney disease
How Liraglutide Works (And Why That Matters for Stopping) Understanding the pharmacology helps explain what happens during discontinuation